Squarepoint’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-4,728
| Closed | -$175K | – | 2496 |
|
2023
Q3 | $175K | Buy |
4,728
+1,825
| +63% | +$67.5K | ﹤0.01% | 2154 |
|
2023
Q2 | $117K | Sell |
2,903
-1,368
| -32% | -$55.1K | ﹤0.01% | 2182 |
|
2023
Q1 | $310K | Buy |
4,271
+2,641
| +162% | +$191K | ﹤0.01% | 1660 |
|
2022
Q4 | $134K | Sell |
1,630
-6,526
| -80% | -$535K | ﹤0.01% | 1997 |
|
2022
Q3 | $771K | Buy |
+8,156
| New | +$771K | ﹤0.01% | 1198 |
|
2021
Q2 | – | Sell |
-4,754
| Closed | -$1.71M | – | 2608 |
|
2021
Q1 | $1.71M | Buy |
4,754
+2,095
| +79% | +$752K | 0.01% | 796 |
|
2020
Q4 | $1.31M | Buy |
2,659
+442
| +20% | +$217K | 0.01% | 938 |
|
2020
Q3 | $718K | Sell |
2,217
-3,384
| -60% | -$1.1M | 0.01% | 1123 |
|
2020
Q2 | $2.04M | Buy |
5,601
+4,034
| +257% | +$1.47M | 0.03% | 617 |
|
2020
Q1 | $333K | Buy |
1,567
+856
| +120% | +$182K | 0.01% | 1246 |
|
2019
Q4 | $293K | Sell |
711
-286
| -29% | -$118K | ﹤0.01% | 1982 |
|
2019
Q3 | $352K | Buy |
+997
| New | +$352K | ﹤0.01% | 1732 |
|
2019
Q2 | – | Sell |
-1,159
| Closed | -$1.15M | – | 2286 |
|
2019
Q1 | $1.15M | Buy |
1,159
+501
| +76% | +$498K | 0.01% | 1025 |
|
2018
Q4 | $571K | Sell |
658
-294
| -31% | -$255K | 0.01% | 1166 |
|
2018
Q3 | $984K | Sell |
952
-464
| -33% | -$480K | 0.01% | 993 |
|
2018
Q2 | $1.3M | Buy |
1,416
+968
| +216% | +$889K | 0.02% | 791 |
|
2018
Q1 | $437K | Sell |
448
-370
| -45% | -$361K | 0.01% | 1134 |
|
2017
Q4 | $370K | Buy |
+818
| New | +$370K | 0.01% | 1365 |
|
2017
Q1 | – | Sell |
-407
| Closed | -$145K | – | 1510 |
|
2016
Q4 | $145K | Buy |
+407
| New | +$145K | 0.01% | 1548 |
|
2016
Q2 | – | Sell |
-648
| Closed | -$308K | – | 1094 |
|
2016
Q1 | $308K | Buy |
648
+336
| +108% | +$160K | 0.02% | 813 |
|
2015
Q4 | $206K | Buy |
+312
| New | +$206K | 0.02% | 981 |
|